Nootropil: Enhance Cognitive Function with Piracetam Therapy
| Product dosage: 800mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $1.11 | $66.33 (0%) | 🛒 Add to cart |
| 90 | $1.07 | $99.49 $96.48 (3%) | 🛒 Add to cart |
| 120 | $1.05 | $132.66 $125.62 (5%) | 🛒 Add to cart |
| 180 | $1.03 | $198.99 $184.92 (7%) | 🛒 Add to cart |
| 270 | $1.02 | $298.48 $274.36 (8%) | 🛒 Add to cart |
| 360 | $1.01
Best per pill | $397.97 $364.81 (8%) | 🛒 Add to cart |
Synonyms
| |||
Nootropil, the pioneering brand of piracetam, represents a cornerstone in the pharmacological management of cognitive disorders. As the original and most extensively researched nootropic agent, it functions by modulating neurotransmission, enhancing neuroplasticity, and improving cerebral microcirculation without acting as a sedative or stimulant. Clinically, it is indicated for a range of conditions where cortical myoclonus or cognitive deficits are present, offering a well-tolerated profile for long-term neurological support. Its mechanism, though not fully elucidated, is believed to involve positive allosteric modulation of AMPA receptors and influences on membrane fluidity, making it a unique therapeutic option.
Features
- Active Ingredient: Piracetam (chemical name: 2-oxo-1-pyrrolidine acetamide)
- Available Formulations: Film-coated tablets (800 mg, 1200 mg), oral solution (20% w/v), and injectable solutions
- Pharmacokinetics: Rapid and almost complete absorption orally; bioavailability approximates 100%
- Half-life: Approximately 5 hours in plasma, with renal excretion as the primary elimination route
- Prescription Status: Available by prescription in most jurisdictions, classified as a nootropic/smart drug
Benefits
- Supports improvement in learning capacity and memory consolidation through enhanced neuronal communication
- Reduces the frequency and severity of cortical myoclonus seizures in susceptible patients
- May aid in recovery from post-stroke aphasia and other vascular cognitive impairments
- Promotes neuroprotection by stabilizing neuronal membranes and mitigating oxidative stress
- Enhances interhemispheric transfer of information via the corpus callosum, supporting integrative brain function
- Provides a favorable safety profile with minimal abuse potential or psychotropic effects
Common use
Nootropil (piracetam) is primarily indicated for the management of cortical myoclonus, either as monotherapy or as an adjunct to other anticonvulsants. It is also used off-label or in specific regions for cognitive enhancement in age-related memory decline, dyslexia, vertigo of central origin, and sickle cell anemia-related vaso-occlusive complications. In clinical neurology, it is sometimes employed to support recovery after ischemic stroke or traumatic brain injury, leveraging its rheological and neuroprotective properties.
Dosage and direction
Dosage must be individualized based on indication, patient response, and renal function. For cortical myoclonus in adults: initial dose is typically 7.2 g/day, divided into 2–3 doses, increasing by 4.8 g/day every 3–4 days up to a maximum of 24 g/day. Maintenance doses usually range between 12–24 g/day. For cognitive disorders: common dosages are 2.4–4.8 g/day in divided doses. Administration with or without food is acceptable, though consistency is advised. In patients with renal impairment, dosage adjustment is necessary—consult prescribing information for creatinine clearance-based guidelines.
Precautions
Use with caution in patients with a history of hemorrhagic diathesis or those undergoing major surgical procedures due to potential effects on hemostasis. Periodic monitoring of renal function is advised during long-term therapy. Elderly patients may require dose adjustments based on renal status. There is limited data on use during pregnancy and lactation—use only if potential benefit justifies potential risk. Avoid abrupt discontinuation in epileptic patients to prevent rebound seizures.
Contraindications
Nootropil is contraindicated in patients with known hypersensitivity to piracetam or any excipients in the formulation. It is also contraindicated in those with severe renal impairment (creatinine clearance <20 mL/min) and patients with cerebral hemorrhage. Should not be used in individuals with Huntington’s chorea due to risk of exacerbating symptoms.
Possible side effect
Most adverse reactions are mild and dose-dependent. Common side effects include:
- Nervousness, anxiety, or hyperkinesia (especially at higher doses)
- Gastrointestinal disturbances such as nausea, vomiting, or diarrhea
- Weight gain
- Dizziness, somnolence, or insomnia
- Rash or pruritus Rare but serious side effects may include severe dermatological reactions, hematological abnormalities, or exacerbation of pre-existing movement disorders.
Drug interaction
Piracetam may potentiate the effects of anticoagulants (e.g., warfarin), antiplatelet agents, and NSAIDs, increasing bleeding risk. Concurrent use with other nootropic or psychotropic agents may lead to additive CNS effects. It might reduce the efficacy of thyroid hormone replacement therapy. No significant interactions with cytochrome P450 substrates have been noted, but caution is advised when combining with other renally excreted drugs.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next dose. Do not double the dose to make up for a missed one. Maintain regular dosing schedule to ensure stable plasma concentrations.
Overdose
Symptoms of overdose may include severe diarrhea, abdominal pain, and pronounced nervousness or agitation. There is no specific antidote; treatment is supportive and symptomatic. Hemodialysis may be effective due to piracetam’s low molecular weight and minimal protein binding. Contact a poison control center or healthcare provider immediately in suspected overdose.
Storage
Store at room temperature (15–30°C), protected from light and moisture. Keep oral solution in the original container; do not freeze. Keep out of reach of children and pets. Do not use after the expiration date printed on packaging.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or altering any medication regimen. Dosage, indications, and legal status may vary by country—refer to local prescribing information.
Reviews
Clinical studies and meta-analyses generally support the efficacy of piracetam in cortical myoclonus and certain cognitive conditions, though evidence for off-label uses remains mixed. Many neurologists report positive outcomes in compliant patients, particularly when used as part of a comprehensive treatment plan. Patient testimonials often highlight improvements in mental clarity and recall, though individual responses vary. Long-term safety data is robust, contributing to its continued use decades after introduction.